Inventor · disambiguated record
Chuansheng Ge
Also filed as: GE CHUANSHENG
30 granted patents·9 pending applications·490 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
39 records- 0199US7893101B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2008·Granted Feb 22, 2011·44 cites·15 claims
- 0298US7427638B2(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereofCELGENE CORP·Filed 2005·Granted Sep 23, 2008·53 cites·13 claims
- 0398US6962940B2(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereofCELGENE CORP·Filed 2003·Granted Nov 8, 2005·107 cites·23 claims
- 0497US8455536B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dioneMULLER GEORGE W·Filed 2009·Granted Jun 4, 2013·28 cites·56 claims
- 0597US7659302B2Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2008·Granted Feb 9, 2010·35 cites·20 claims
- 0696US9018243B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2013·Granted Apr 28, 2015·13 cites·21 claims
- 0796US8093283B2Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2010·Granted Jan 10, 2012·17 cites·42 claims
- 0896US7659303B2Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2008·Granted Feb 9, 2010·21 cites·14 claims
- 0996US7507759B2Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dioneCELGENE CORP·Filed 2007·Granted Mar 24, 2009·21 cites·11 claims
- 1096US7358272B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2005·Granted Apr 15, 2008·21 cites·17 claims
- 1195US8802717B2Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2012·Granted Aug 12, 2014·13 cites·22 claims
- 1295US8629173B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2011·Granted Jan 14, 2014·11 cites·39 claims
- 1395US7994327B2Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compoundsCELGENE CORP·Filed 2006·Granted Aug 9, 2011·28 cites·13 claims
- 1494US9724330B2Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2016·Granted Aug 8, 2017·7 cites·33 claims
- 1591US10092542B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2017·Granted Oct 9, 2018·4 cites·17 claims
- 1691US9283207B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2014·Granted Mar 15, 2016·7 cites·24 claims
- 1790US9433606B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2015·Granted Sep 6, 2016·3 cites·15 claims
- 1888US8242310B2Processes for the preparation of aminosulfone compoundsSAINDANE MANOHAR T·Filed 2009·Granted Aug 14, 2012·9 cites·24 claims
- 1988US7863451B2Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolinesCELGENE CORP·Filed 2005·Granted Jan 4, 2011·12 cites·55 claims
- 2087US10610516B2Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dioneAMGEN INC·Filed 2018·Granted Apr 7, 2020·1 cites·15 claims
- 2187US10017492B2Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2015·Granted Jul 10, 2018·9 cites·23 claims
- 2286US6359139B1Methods for production of piperidyl acetamide stereoisomersCELGENE CORP·Filed 2000·Granted Mar 19, 2002·19 cites·21 claims
- 2378US11260046B2(+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereofAMGEN INC·Filed 2020·Granted Mar 1, 2022·0 cites·7 claims
- 2478US8785644B2Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compoundsGE CHUANSHENG·Filed 2011·Granted Jul 22, 2014·4 cites·11 claims
- 2578US2024173312A1Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application ThereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 2677US2024139156A1Combination treating prostate cancer, pharmaceutical composition and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 2776US11040024B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneAMGEN INC·Filed 2020·Granted Jun 22, 2021·0 cites·5 claims
- 2875US9822093B2Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compoundsCELGENE CORP·Filed 2016·Granted Nov 21, 2017·1 cites·15 claims
- 2975US8415485B2Processes for the preparation of 2-(1-phenylethyl)isoindolin-1-one compoundsFRANK ANTHONY J·Filed 2010·Granted Apr 9, 2013·2 cites·17 claims
- 3066US2021267946A1Combination treating prostate cancer, pharmaceutical composition and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3165US10266514B2Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compoundsCELGENE CORP·Filed 2017·Granted Apr 23, 2019·0 cites·6 claims
- 3265US9394274B2Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compoundsCELGENE CORP·Filed 2014·Granted Jul 19, 2016·0 cites·5 claims
- 3364US2021113545A1Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application ThereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 3459US2020000776A1Combination treating prostate cancer, pharmaceutical composition and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3553US2023114674A1Isoindoline derivative, and pharmaceutical composition and use thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3650US10933059B2Combination, application thereof and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2017·Granted Mar 2, 2021·0 cites·17 claims
- 3749US2018271849A1Pharmaceutical composition and application thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 3846US2008064876A1Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dioneMULLER GEORGE W·Filed 2007·Application pending·0 cites
- 3944US2006258706A1Solid forms of a JNK inhibitorSAINDANE MANOHAR·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chuansheng Ge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →